(Q43642324)

25 November 2017

title

Levofloxacin failure in a patient with pneumococcal pneumonia (English)

1 reference

25 November 2017

1 reference

1 reference

1 reference

P E Empey

1

1 reference

25 November 2017

H R Jennings

2

1 reference

25 November 2017

A C Thornton

3

1 reference

25 November 2017

R P Rapp

4

1 reference

25 November 2017

M E Evans

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Annals of Pharmacotherapy

25 November 2017

published in

1 reference

25 November 2017

volume

35

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

687-690

1 reference

The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project

25 November 2017

cites work

1 reference

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

21 January 2018

1 reference

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

21 January 2018

1 reference

A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.

21 January 2018

1 reference

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

21 January 2018

1 reference

In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance.

21 January 2018

1 reference

In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.

21 January 2018

1 reference

In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance

21 January 2018

1 reference

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

21 January 2018

1 reference

Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis

21 January 2018

1 reference

In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program

21 January 2018

1 reference

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

21 January 2018

1 reference

Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study

21 January 2018

1 reference

In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae

21 January 2018

1 reference

Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999).

21 January 2018

1 reference

Application of fluoroquinolone pharmacodynamics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.10229

1 reference

25 November 2017

1 reference